The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung ...

Neurons receive thousands of signals via tree-like extensions called dendrites. Until now, these dendrites were thought to be ...

Risk factors for cardiovascular-kidney-metabolic disease, a health condition made up of heart disease, kidney disease, ...

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, ...

Early and consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent ...

Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients with previously ...

Patients with resectable stage II–IIIB non-small cell lung cancer (NSCLC) treated with perioperative atezolizumab plus ...

An integrative review found that ketogenic therapy may influence metabolic, inflammatory, oxidative stress, and ...

Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), ...

A new Ontario-wide study reveals that common medications, from statins to iron supplements, are quietly setting off ...

Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall ...

A multidisciplinary scientific team at the University of Malaga has developed a new technology based on magnetic ...